Detailed price information for Fortress Biotech Inc (FBIO-Q) from The Globe and Mail including charting and trades.

Detailed price information for Fortress Biotech Inc 9.375% Series A Cumulativ (FBIOP-Q) from The Globe and Mail including charting and trades.

Total net revenue increased 20.5% to $17.6 million for third quarter of 2025 compared to the third quarter of 2024 Fortress subsidiary Checkpoint Therapeutics acquired by Sun Pharma; Fortress received ...

Probiotics contain different types of micro-organisms such as yeast (saccharomyces boulardii) and bacteria (such as lactobacillus, bifidobacterium). Micro-organisms (flora) are naturally found in the ...

Ranbaxy Laboratories view the history of various companies ...

Journey Medical Corporation a commercial-stage pharmaceutical company primarily focused on selling and marketing FDA-approved prescription pharmaceutical products for the treatment of dermatological ...